Novartis’ Ianalumab Demonstrates Potential in Phase 3 Sjögren’s Syndrome Trials
Novartis' ianalumab has shown promise in Phase 3 clinical trials for the treatment of Sjögren's…
Tue. Sep 9th, 2025
Trending
Netflix Unveils Thrilling First Look at New Series, Leaving Fans on the Edge of Their Seats
Teacher Sparks Online Debate After Slamming Parent’s Comment on SK Kids
Nigeria Mourns: Kogi Government Pays Tribute to Late ITF Boss Olu Akerejola
India Unveils Cutting-Edge Monitoring System for Atal Residential Schools
USTAHEC Scholars: Empowering Future Leaders in the Philippines